Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Luminescent Measurements | 18 | 2021 | 405 | 4.790 |
Why?
|
Luciferases | 12 | 2021 | 733 | 3.360 |
Why?
|
Luminescent Agents | 3 | 2021 | 54 | 2.220 |
Why?
|
Luciferases, Firefly | 7 | 2020 | 46 | 2.080 |
Why?
|
Luminescence | 7 | 2020 | 137 | 1.550 |
Why?
|
Luminescent Proteins | 4 | 2020 | 853 | 1.550 |
Why?
|
Cell Tracking | 2 | 2021 | 144 | 1.140 |
Why?
|
Firefly Luciferin | 3 | 2020 | 10 | 0.970 |
Why?
|
Furans | 2 | 2021 | 193 | 0.860 |
Why?
|
Stem Cell Transplantation | 5 | 2020 | 1620 | 0.790 |
Why?
|
Hair Follicle | 3 | 2020 | 209 | 0.780 |
Why?
|
Genes, Reporter | 8 | 2021 | 1545 | 0.780 |
Why?
|
Mice, Nude | 10 | 2021 | 3680 | 0.770 |
Why?
|
Molecular Imaging | 4 | 2017 | 821 | 0.740 |
Why?
|
Benzothiazoles | 3 | 2019 | 247 | 0.700 |
Why?
|
Nanoparticles | 5 | 2019 | 1898 | 0.670 |
Why?
|
HEK293 Cells | 9 | 2023 | 4204 | 0.660 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2021 | 717 | 0.650 |
Why?
|
Imidazoles | 3 | 2021 | 1206 | 0.620 |
Why?
|
Whole Body Imaging | 3 | 2021 | 282 | 0.610 |
Why?
|
Pyrazines | 2 | 2021 | 1230 | 0.610 |
Why?
|
Insect Proteins | 1 | 2018 | 255 | 0.560 |
Why?
|
Retinal Vessels | 1 | 2021 | 772 | 0.520 |
Why?
|
Virus Diseases | 1 | 2020 | 711 | 0.480 |
Why?
|
Nanomedicine | 1 | 2017 | 302 | 0.470 |
Why?
|
Nanotechnology | 1 | 2019 | 708 | 0.440 |
Why?
|
Biosensing Techniques | 4 | 2023 | 667 | 0.390 |
Why?
|
Mice, Inbred BALB C | 8 | 2021 | 6380 | 0.380 |
Why?
|
Animals | 41 | 2023 | 168660 | 0.360 |
Why?
|
NF-kappa B | 2 | 2016 | 2500 | 0.330 |
Why?
|
Mesenchymal Stem Cells | 2 | 2020 | 1632 | 0.310 |
Why?
|
Mice | 22 | 2023 | 81154 | 0.310 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2217 | 0.300 |
Why?
|
Neural Stem Cells | 1 | 2013 | 851 | 0.280 |
Why?
|
Carbocyanines | 2 | 2016 | 173 | 0.270 |
Why?
|
Injections, Intraperitoneal | 2 | 2020 | 424 | 0.260 |
Why?
|
Structure-Activity Relationship | 2 | 2021 | 3128 | 0.260 |
Why?
|
Stem Cells | 4 | 2020 | 3566 | 0.250 |
Why?
|
Macrophages | 1 | 2019 | 5651 | 0.240 |
Why?
|
Single-Cell Analysis | 1 | 2014 | 2177 | 0.230 |
Why?
|
Staining and Labeling | 2 | 2020 | 1098 | 0.230 |
Why?
|
Neoplasms | 6 | 2023 | 21675 | 0.230 |
Why?
|
Indium Radioisotopes | 2 | 2020 | 118 | 0.230 |
Why?
|
Temperature | 1 | 2009 | 2202 | 0.220 |
Why?
|
Cell Line, Tumor | 12 | 2021 | 16674 | 0.220 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2016 | 3547 | 0.220 |
Why?
|
Immunologic Tests | 1 | 2023 | 103 | 0.220 |
Why?
|
Blood-Brain Barrier | 2 | 2021 | 1018 | 0.220 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4477 | 0.210 |
Why?
|
Lung | 1 | 2021 | 9858 | 0.210 |
Why?
|
Photons | 2 | 2020 | 588 | 0.210 |
Why?
|
Substrate Specificity | 2 | 2020 | 1802 | 0.200 |
Why?
|
Cochlea | 2 | 2019 | 828 | 0.200 |
Why?
|
Lentivirus Infections | 1 | 2021 | 12 | 0.200 |
Why?
|
Gallium Radioisotopes | 1 | 2021 | 178 | 0.190 |
Why?
|
Color | 4 | 2012 | 304 | 0.190 |
Why?
|
Apoptosis | 2 | 2016 | 9718 | 0.190 |
Why?
|
Brain | 3 | 2017 | 26345 | 0.180 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4033 | 0.180 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 418 | 0.170 |
Why?
|
Solubility | 1 | 2021 | 1088 | 0.170 |
Why?
|
Cell Membrane Permeability | 1 | 2021 | 589 | 0.170 |
Why?
|
Liver Transplantation | 2 | 2020 | 2119 | 0.160 |
Why?
|
Spectrometry, Fluorescence | 1 | 2020 | 688 | 0.160 |
Why?
|
Caspase 7 | 2 | 2016 | 56 | 0.150 |
Why?
|
Contrast Media | 2 | 2021 | 5301 | 0.150 |
Why?
|
Cell Survival | 3 | 2017 | 5881 | 0.150 |
Why?
|
Organ Preservation | 1 | 2020 | 331 | 0.150 |
Why?
|
Thrombophlebitis | 1 | 1997 | 309 | 0.150 |
Why?
|
Ovalbumin | 2 | 2019 | 719 | 0.140 |
Why?
|
Oncolytic Viruses | 1 | 2020 | 327 | 0.140 |
Why?
|
Adenoviridae | 1 | 2020 | 1100 | 0.140 |
Why?
|
Chondrogenesis | 1 | 2017 | 247 | 0.140 |
Why?
|
Bandages | 1 | 1997 | 266 | 0.140 |
Why?
|
Biological Assay | 2 | 2010 | 650 | 0.130 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2020 | 1108 | 0.130 |
Why?
|
Brain Neoplasms | 2 | 2017 | 8856 | 0.130 |
Why?
|
Perfusion | 1 | 2020 | 1359 | 0.130 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 2 | 2012 | 30 | 0.130 |
Why?
|
End Stage Liver Disease | 1 | 2019 | 314 | 0.130 |
Why?
|
Caspase 3 | 2 | 2016 | 758 | 0.130 |
Why?
|
Indoles | 2 | 2020 | 1841 | 0.130 |
Why?
|
Adipogenesis | 1 | 2017 | 357 | 0.130 |
Why?
|
Activin Receptors, Type II | 1 | 2015 | 127 | 0.130 |
Why?
|
Oligopeptides | 1 | 2020 | 1188 | 0.130 |
Why?
|
Necrosis | 4 | 2021 | 1642 | 0.120 |
Why?
|
Humans | 44 | 2023 | 743811 | 0.120 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2020 | 496 | 0.120 |
Why?
|
Light | 1 | 2021 | 1365 | 0.120 |
Why?
|
Pentacyclic Triterpenes | 1 | 2014 | 37 | 0.120 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3583 | 0.120 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 21824 | 0.120 |
Why?
|
Cell Line | 6 | 2021 | 15993 | 0.110 |
Why?
|
Triterpenes | 1 | 2014 | 80 | 0.110 |
Why?
|
Infrared Rays | 1 | 2014 | 249 | 0.110 |
Why?
|
Cell Differentiation | 3 | 2020 | 11478 | 0.110 |
Why?
|
Gene Expression | 4 | 2021 | 7793 | 0.110 |
Why?
|
Polyesters | 1 | 2014 | 362 | 0.110 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2015 | 520 | 0.110 |
Why?
|
Surgery, Computer-Assisted | 1 | 2021 | 1017 | 0.110 |
Why?
|
Chlamydophila pneumoniae | 1 | 2012 | 55 | 0.110 |
Why?
|
Hep G2 Cells | 2 | 2012 | 393 | 0.110 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2012 | 35 | 0.110 |
Why?
|
Drug Carriers | 1 | 2017 | 690 | 0.100 |
Why?
|
Tumor Burden | 3 | 2015 | 1917 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 3 | 2016 | 3772 | 0.100 |
Why?
|
Mice, Transgenic | 2 | 2021 | 9731 | 0.100 |
Why?
|
Chemoprevention | 1 | 2014 | 319 | 0.100 |
Why?
|
Cell Proliferation | 2 | 2017 | 10477 | 0.100 |
Why?
|
Thromboembolism | 1 | 1997 | 987 | 0.100 |
Why?
|
Lentivirus | 1 | 2014 | 503 | 0.100 |
Why?
|
Heparin | 2 | 1997 | 1637 | 0.090 |
Why?
|
Immunotherapy | 2 | 2017 | 4437 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6620 | 0.090 |
Why?
|
Microscopy, Fluorescence | 1 | 2018 | 2692 | 0.090 |
Why?
|
Saccharomyces cerevisiae | 3 | 2011 | 2750 | 0.090 |
Why?
|
Absorption | 1 | 2009 | 248 | 0.090 |
Why?
|
Alprostadil | 2 | 2000 | 89 | 0.090 |
Why?
|
Enzyme Stability | 1 | 2009 | 210 | 0.090 |
Why?
|
Photochemotherapy | 1 | 2015 | 808 | 0.080 |
Why?
|
Codon | 1 | 2011 | 611 | 0.080 |
Why?
|
Disease Models, Animal | 7 | 2019 | 18027 | 0.080 |
Why?
|
Warfarin | 1 | 1997 | 1497 | 0.080 |
Why?
|
Cells | 1 | 2010 | 167 | 0.080 |
Why?
|
SOX9 Transcription Factor | 1 | 2009 | 146 | 0.080 |
Why?
|
Copper | 1 | 2011 | 366 | 0.080 |
Why?
|
Liver | 3 | 2020 | 7479 | 0.080 |
Why?
|
Organisms, Genetically Modified | 1 | 2008 | 64 | 0.080 |
Why?
|
Cell Count | 2 | 2009 | 1855 | 0.080 |
Why?
|
Gastric Emptying | 1 | 2010 | 233 | 0.080 |
Why?
|
Food Preservation | 1 | 2007 | 14 | 0.080 |
Why?
|
Carcinoembryonic Antigen | 1 | 2009 | 349 | 0.080 |
Why?
|
Tuna | 1 | 2007 | 19 | 0.080 |
Why?
|
Cytomegalovirus | 1 | 2012 | 733 | 0.080 |
Why?
|
Perciformes | 1 | 2007 | 18 | 0.080 |
Why?
|
Fibrinolytic Agents | 1 | 1997 | 2159 | 0.080 |
Why?
|
Genetic Vectors | 2 | 2016 | 3421 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1903 | 0.080 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2009 | 277 | 0.080 |
Why?
|
Water Pollutants, Chemical | 1 | 2011 | 311 | 0.080 |
Why?
|
Breast Neoplasms | 2 | 2016 | 20827 | 0.070 |
Why?
|
Graft Survival | 2 | 2016 | 3734 | 0.070 |
Why?
|
Intermittent Claudication | 2 | 2000 | 309 | 0.070 |
Why?
|
Microfluidics | 2 | 2023 | 662 | 0.070 |
Why?
|
Biomedical Research | 1 | 2022 | 3308 | 0.070 |
Why?
|
Reference Standards | 2 | 2022 | 1023 | 0.070 |
Why?
|
Molecular Probes | 1 | 2009 | 315 | 0.070 |
Why?
|
Decision Making | 1 | 2021 | 3887 | 0.070 |
Why?
|
Lymphoma | 1 | 2015 | 1875 | 0.070 |
Why?
|
Proteomics | 2 | 2010 | 3639 | 0.070 |
Why?
|
Graft Rejection | 1 | 2019 | 4398 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4386 | 0.070 |
Why?
|
Vaccines | 1 | 2014 | 823 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4422 | 0.070 |
Why?
|
Female | 16 | 2021 | 380020 | 0.070 |
Why?
|
Shoulder Dislocation | 1 | 1986 | 122 | 0.070 |
Why?
|
Genetic Techniques | 1 | 2008 | 435 | 0.060 |
Why?
|
Transfection | 2 | 2012 | 5892 | 0.060 |
Why?
|
Kinetics | 2 | 2010 | 6476 | 0.060 |
Why?
|
Algorithms | 3 | 2021 | 13869 | 0.060 |
Why?
|
Vasodilator Agents | 2 | 2000 | 974 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2638 | 0.060 |
Why?
|
Tissue Distribution | 2 | 2020 | 2327 | 0.060 |
Why?
|
High-Throughput Screening Assays | 1 | 2010 | 944 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3503 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 35409 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2009 | 1602 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3504 | 0.050 |
Why?
|
Anticoagulants | 1 | 1997 | 4599 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.050 |
Why?
|
Drug Discovery | 1 | 2010 | 1058 | 0.050 |
Why?
|
Male | 12 | 2021 | 349776 | 0.050 |
Why?
|
Escherichia coli | 2 | 2011 | 4216 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 13980 | 0.050 |
Why?
|
Radiopharmaceuticals | 2 | 2021 | 2647 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2012 | 7719 | 0.050 |
Why?
|
Androgens | 1 | 2008 | 1247 | 0.050 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2020 | 65 | 0.050 |
Why?
|
Coculture Techniques | 2 | 2017 | 1342 | 0.050 |
Why?
|
Epitopes | 2 | 2019 | 2570 | 0.050 |
Why?
|
Intraoperative Period | 1 | 2021 | 520 | 0.040 |
Why?
|
Spleen | 2 | 2019 | 2359 | 0.040 |
Why?
|
Cell Death | 2 | 2015 | 1705 | 0.040 |
Why?
|
Intestines | 1 | 2009 | 1923 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14714 | 0.040 |
Why?
|
Antigens, CD | 1 | 2009 | 4026 | 0.040 |
Why?
|
Fluorescence | 1 | 2021 | 752 | 0.040 |
Why?
|
Ultrasonography | 4 | 2022 | 5986 | 0.040 |
Why?
|
Paracrine Communication | 1 | 2020 | 278 | 0.040 |
Why?
|
Sus scrofa | 1 | 2020 | 438 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2009 | 3038 | 0.040 |
Why?
|
Mice, Inbred CBA | 1 | 2019 | 448 | 0.040 |
Why?
|
Neurons | 1 | 2017 | 9336 | 0.040 |
Why?
|
Microscopy | 1 | 2023 | 896 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6170 | 0.040 |
Why?
|
Guinea Pigs | 1 | 2019 | 1386 | 0.040 |
Why?
|
Time Factors | 3 | 2014 | 40038 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2020 | 690 | 0.040 |
Why?
|
NFATC Transcription Factors | 1 | 2019 | 381 | 0.040 |
Why?
|
Pentetic Acid | 1 | 2016 | 213 | 0.040 |
Why?
|
Disease Progression | 2 | 2012 | 13273 | 0.040 |
Why?
|
DNA | 2 | 2008 | 7295 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 1574 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2009 | 3690 | 0.040 |
Why?
|
Crohn Disease | 1 | 2009 | 2304 | 0.030 |
Why?
|
Leg | 2 | 2000 | 1116 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 1997 | 667 | 0.030 |
Why?
|
Quantitative Structure-Activity Relationship | 1 | 2015 | 29 | 0.030 |
Why?
|
Growth Differentiation Factor 2 | 1 | 2015 | 29 | 0.030 |
Why?
|
Dendritic Cells | 2 | 2019 | 2720 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2010 | 2428 | 0.030 |
Why?
|
Costs and Cost Analysis | 2 | 1998 | 1680 | 0.030 |
Why?
|
Vaccines, Subunit | 1 | 2015 | 168 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 1181 | 0.030 |
Why?
|
Fracture Fixation, Intramedullary | 2 | 1986 | 156 | 0.030 |
Why?
|
Genetic Engineering | 2 | 2011 | 950 | 0.030 |
Why?
|
Magnetics | 1 | 2016 | 604 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2016 | 913 | 0.030 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2015 | 278 | 0.030 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2014 | 407 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 29777 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2172 | 0.030 |
Why?
|
Tibial Fractures | 2 | 1986 | 269 | 0.030 |
Why?
|
Chlamydophila Infections | 1 | 2012 | 23 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23398 | 0.030 |
Why?
|
Hepatocytes | 1 | 2019 | 1211 | 0.030 |
Why?
|
Femoral Fractures | 2 | 1986 | 376 | 0.030 |
Why?
|
Fireflies | 1 | 2011 | 3 | 0.030 |
Why?
|
Immunomodulation | 1 | 2015 | 541 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2020 | 2378 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2022 | 1880 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2015 | 644 | 0.020 |
Why?
|
Ischemia | 1 | 2000 | 1907 | 0.020 |
Why?
|
Photosensitizing Agents | 1 | 2015 | 602 | 0.020 |
Why?
|
Cations, Divalent | 1 | 2011 | 166 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1794 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2086 | 0.020 |
Why?
|
Stroke | 1 | 2013 | 9975 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2429 | 0.020 |
Why?
|
Metoclopramide | 1 | 2010 | 51 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2018 | 2479 | 0.020 |
Why?
|
Scopolamine | 1 | 2010 | 99 | 0.020 |
Why?
|
Administration, Oral | 1 | 1997 | 3912 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3208 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 1962 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2012 | 294 | 0.020 |
Why?
|
Methods | 2 | 1986 | 1128 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2014 | 1283 | 0.020 |
Why?
|
Antiemetics | 1 | 2010 | 177 | 0.020 |
Why?
|
Immunity | 1 | 2014 | 1013 | 0.020 |
Why?
|
Electrochemistry | 1 | 2008 | 145 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2012 | 2085 | 0.020 |
Why?
|
Frozen Foods | 1 | 2007 | 1 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2009 | 435 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2015 | 1023 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2009 | 545 | 0.020 |
Why?
|
Chenodeoxycholic Acid | 1 | 2007 | 34 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2012 | 671 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5524 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 1876 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2015 | 1988 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2010 | 501 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1997 | 2715 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1656 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2019 | 3476 | 0.020 |
Why?
|
Flatfoot | 1 | 1987 | 55 | 0.020 |
Why?
|
Fraud | 1 | 2007 | 67 | 0.020 |
Why?
|
Mice, SCID | 1 | 2012 | 2718 | 0.020 |
Why?
|
Bone Lengthening | 1 | 1986 | 19 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3275 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7908 | 0.020 |
Why?
|
Leg Length Inequality | 1 | 1986 | 55 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2009 | 669 | 0.020 |
Why?
|
Arm | 2 | 1986 | 588 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2012 | 1813 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2021 | 6237 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 2556 | 0.020 |
Why?
|
Research Design | 1 | 2021 | 5983 | 0.020 |
Why?
|
Pulmonary Embolism | 1 | 1997 | 2375 | 0.020 |
Why?
|
Bone Nails | 1 | 1986 | 219 | 0.020 |
Why?
|
Water | 1 | 2011 | 1394 | 0.020 |
Why?
|
Triglycerides | 1 | 2012 | 2453 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2012 | 1581 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8637 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2890 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 1213 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2011 | 19894 | 0.010 |
Why?
|
Muscles | 1 | 2007 | 1613 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2008 | 1055 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 8939 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2009 | 2203 | 0.010 |
Why?
|
Lymphocytes | 1 | 2009 | 2615 | 0.010 |
Why?
|
Colon | 1 | 2009 | 1772 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14563 | 0.010 |
Why?
|
Phylogeny | 1 | 2007 | 2796 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1984 | 793 | 0.010 |
Why?
|
Proteome | 1 | 2009 | 1794 | 0.010 |
Why?
|
Radiography | 2 | 1986 | 7010 | 0.010 |
Why?
|
Orthopedics | 1 | 1987 | 904 | 0.010 |
Why?
|
Bacteria | 1 | 2009 | 2112 | 0.010 |
Why?
|
Blood Glucose | 1 | 2012 | 6259 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10940 | 0.010 |
Why?
|
International Cooperation | 1 | 1984 | 1419 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1984 | 1504 | 0.010 |
Why?
|
Peptides | 1 | 2009 | 4406 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 1997 | 39001 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12798 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12209 | 0.010 |
Why?
|
Exercise Test | 2 | 1998 | 2074 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11524 | 0.010 |
Why?
|
Recurrence | 1 | 1986 | 8337 | 0.010 |
Why?
|
Software | 1 | 2009 | 4440 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 18107 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1998 | 2274 | 0.010 |
Why?
|
Proteins | 1 | 2009 | 6098 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 19232 | 0.010 |
Why?
|
Walking | 1 | 2000 | 1182 | 0.010 |
Why?
|
Drug Costs | 1 | 2000 | 1105 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13691 | 0.010 |
Why?
|
Europe | 1 | 1998 | 3336 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29052 | 0.010 |
Why?
|
Inflammation | 1 | 2009 | 10629 | 0.010 |
Why?
|
Adolescent | 5 | 1987 | 85729 | 0.000 |
Why?
|
Foot Deformities, Congenital | 1 | 1987 | 59 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 2000 | 5388 | 0.000 |
Why?
|
Pilot Projects | 1 | 2000 | 8316 | 0.000 |
Why?
|
Middle Aged | 5 | 2000 | 213241 | 0.000 |
Why?
|
Pain | 1 | 2000 | 4987 | 0.000 |
Why?
|
Dicumarol | 1 | 1984 | 6 | 0.000 |
Why?
|
Plethysmography, Impedance | 1 | 1984 | 43 | 0.000 |
Why?
|
Pulse | 1 | 1984 | 228 | 0.000 |
Why?
|
Blood Circulation | 1 | 1984 | 251 | 0.000 |
Why?
|
Treatment Outcome | 2 | 2000 | 63042 | 0.000 |
Why?
|
Mitral Valve Prolapse | 1 | 1984 | 231 | 0.000 |
Why?
|
Embolism | 1 | 1984 | 407 | 0.000 |
Why?
|
Constriction, Pathologic | 1 | 1984 | 1108 | 0.000 |
Why?
|
Adult | 4 | 1986 | 213889 | 0.000 |
Why?
|
Cerebral Angiography | 1 | 1984 | 1285 | 0.000 |
Why?
|
Carotid Artery Diseases | 1 | 1984 | 875 | 0.000 |
Why?
|
Aged | 3 | 2000 | 163178 | 0.000 |
Why?
|
Intracranial Aneurysm | 1 | 1984 | 1197 | 0.000 |
Why?
|
Cerebral Hemorrhage | 1 | 1984 | 2647 | 0.000 |
Why?
|
Brain Ischemia | 1 | 1984 | 3264 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1984 | 12954 | 0.000 |
Why?
|
Child | 2 | 1987 | 77637 | 0.000 |
Why?
|
Blood Pressure | 1 | 1984 | 8551 | 0.000 |
Why?
|
Infant | 1 | 1986 | 35122 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1986 | 15281 | 0.000 |
Why?
|
Child, Preschool | 1 | 1986 | 40964 | 0.000 |
Why?
|